Clinical trial
Therapeutic Drug Monitoring-baSed adalimuMab De-escalatiOn in nOn-infecTious cHronic Uveitis: an Open-label, Non-inferiority, Randomised Clinical Trial
NCT06390436 is registered in ClinicalTrials.gov with Centre Hospitalier Universitaire de Saint Etienne as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Therapeutic Drug Monitoring-baSed adalimuMab De-escalatiOn in nOn-infecTious cHronic Uveitis: an Open-label, Non-inferiority, Randomised Clinical Trial
- Lead sponsor
- Centre Hospitalier Universitaire de Saint Etienne
- Phase
- Phase 4
- Overall status
- Not yet recruiting
- Start date
- December 31, 2026
- Completion date
- December 31, 2030
- Enrollment
- 320 (estimated)
- Sites
- 11
Conditions
As the registry lists them; a condition with its own page is linked.